[go: up one dir, main page]

WO1997034144A1 - Procede permettant de detecter l'effet de substances test a l'aide d'urokinase de poule - Google Patents

Procede permettant de detecter l'effet de substances test a l'aide d'urokinase de poule Download PDF

Info

Publication number
WO1997034144A1
WO1997034144A1 PCT/EP1997/001219 EP9701219W WO9734144A1 WO 1997034144 A1 WO1997034144 A1 WO 1997034144A1 EP 9701219 W EP9701219 W EP 9701219W WO 9734144 A1 WO9734144 A1 WO 9734144A1
Authority
WO
WIPO (PCT)
Prior art keywords
urokinase
chicken
cells
plasmid
transfected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1997/001219
Other languages
German (de)
English (en)
Inventor
Gernot Langer
Luisella Toschi
Wolf-Dieter Schleuning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19611780A external-priority patent/DE19611780A1/de
Priority claimed from DE1996154616 external-priority patent/DE19654616A1/de
Application filed by Schering AG filed Critical Schering AG
Priority to AU22873/97A priority Critical patent/AU2287397A/en
Publication of WO1997034144A1 publication Critical patent/WO1997034144A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Definitions

  • transfection reagents are, for example, transfection reagents based on liposomal gene transfer.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un procédé permettant de détecter l'effet de substances test dans des systèmes de culture cellulaire et des substances à l'aide de produits de recombinaison du gène rapporteur du gène urokinase de faible poids moléculaire issu de la poule et de lignées cellulaires recombinées transfectées. L'invention concerne en outre l'utilisation dudit procédé pour analyser des composés et déterminer des récepteurs.
PCT/EP1997/001219 1996-03-14 1997-03-11 Procede permettant de detecter l'effet de substances test a l'aide d'urokinase de poule Ceased WO1997034144A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22873/97A AU2287397A (en) 1996-03-14 1997-03-11 Method of detecting the effect of test substances using hen urokinase

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19611780.1 1996-03-14
DE19611780A DE19611780A1 (de) 1996-03-14 1996-03-14 Verfahren zum Nachweis der Wirkung von Testsubstanzen
DE1996154616 DE19654616A1 (de) 1996-12-20 1996-12-20 Verfahren zum Nachweis der Wirkung von Testsubstanzen unter Verwendung von Hühner-Urokinase
DE19654616.8 1996-12-20

Publications (1)

Publication Number Publication Date
WO1997034144A1 true WO1997034144A1 (fr) 1997-09-18

Family

ID=26024119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/001219 Ceased WO1997034144A1 (fr) 1996-03-14 1997-03-11 Procede permettant de detecter l'effet de substances test a l'aide d'urokinase de poule

Country Status (2)

Country Link
AU (1) AU2287397A (fr)
WO (1) WO1997034144A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007488A1 (fr) * 1989-11-16 1991-05-30 The Salk Institute For Biological Studies Elements de reponse de l'acide retinoique beta; compositions et analyses
US5183736A (en) * 1990-03-30 1993-02-02 La Jolla Cancer Research Foundation Methods using estrogen receptor as a constitutive transcriptional activator and a repressor
WO1995006754A1 (fr) * 1993-09-01 1995-03-09 The Regents Of The University Of California Procedes de detection de composes anti-×strogenes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007488A1 (fr) * 1989-11-16 1991-05-30 The Salk Institute For Biological Studies Elements de reponse de l'acide retinoique beta; compositions et analyses
US5183736A (en) * 1990-03-30 1993-02-02 La Jolla Cancer Research Foundation Methods using estrogen receptor as a constitutive transcriptional activator and a repressor
WO1995006754A1 (fr) * 1993-09-01 1995-03-09 The Regents Of The University Of California Procedes de detection de composes anti-×strogenes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHENG, S. M. ET AL: "Tissue plasminogen activator (tPA) as a reporter gene in transient gene expression", GENE (1987), 58(2-3), 299-303 CODEN: GENED6;ISSN: 0378-1119, 1987, XP002034593 *
LANGER, G. ET AL.: "Low-Mr urokinase-type plasminogen activator as a reporter protein", GENE, vol. 161, 1995, pages 287 - 292, XP002034590 *
LESLIE, N.D. ET AL.: "The chicken Urokinase-type Plasminogen Activator gene", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 3, 1990, pages 1339 - 1334, XP002034591 *
STRÄHLE, U. ET AL.: "Synergistic action of the glucocorticoid receptro with transcription factors.", THE EMBO JOURNAL, vol. 7, no. 11, 1988, pages 3389 - 3395, XP002034594 *
YOKOYAMA-KOBAYASHI, MIDORI ET AL: "A signal sequence detection system using secreted protease activity as an indicator", GENE (1995), 163(2), 193-6 CODEN: GENED6;ISSN: 0378-1119, 1995, XP002034592 *

Also Published As

Publication number Publication date
AU2287397A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
DE68926905T2 (de) Rezeptoren: ihre Identifizierung, Charakterisierung, Herstellung und Verwendung
AU685054C (en) Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
DE69417037T2 (de) Identifizierung von liganden durch selektive vermehrung von, durch rezeptoren tranzfizierten zellen
DE69709561T2 (de) Östrogen-Rezeptor
Breslin et al. Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids
AU637871B2 (en) Beta retinoic acid response elements compositions and assays
DE69011329T2 (de) Pdgf-alpha-rezeptor.
Ito et al. Independent regulation of thymidine kinase mRNA and enzyme levels in serum-stimulated cells.
Pavlin et al. Analysis of regulatory regions in the COL1A1 gene responsible for 1, 25‐dihydroxyvitamin D3‐mediated transcriptional repression in osteoblastic cells
Hoare et al. Identification of a GABPα/β binding site involved in the induction of oxytocin receptor gene expression in human breast cells. Potentiation by c-Fos/c-Jun
DE4317577A1 (de) Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg
DE69231689T2 (de) Zusammensetzung von antwortelementen und ihre verwendung als proben
Qu et al. Generation of multiple mRNA transcripts from the novel human apoptosis-inducing gene hap by alternative polyadenylation utilization and the translational activation function of 3′ untranslated region
Szapary et al. Modulation of glucocorticoid induction of stably transfected tyrosine aminotransferase gene constructs involves elements up-stream of the glucocorticoid-responsive element.
WO1997034144A1 (fr) Procede permettant de detecter l'effet de substances test a l'aide d'urokinase de poule
WO1993022331A9 (fr) Crabp-i et crabp-ii humaines
EP0640093A1 (fr) Crabp-i et crabp-ii humaines
DE19654616A1 (de) Verfahren zum Nachweis der Wirkung von Testsubstanzen unter Verwendung von Hühner-Urokinase
DE19611780A1 (de) Verfahren zum Nachweis der Wirkung von Testsubstanzen
Goethe et al. Regulation of C/EBPβ mRNA expression and C/EBPβ promoter activity by protein kinases A and C in a myelomonocytic cell line (HD11)
DE60030796T2 (de) Zelle zur Bestimmung der Fähigkeit die Aktivität eines Liganden-abhängigen Transkriptionskontrollfaktors zu kontrollieren
Kroeger et al. In vivo occupancy of histone gene proximal promoter elements reflects gene copy number‐dependent titratable transactivation factors and cross‐species compatibility of regulatory sequences
EP1058117B1 (fr) Utilisation de SLIM3 pour la liaison aux molécules
EP1288227B1 (fr) Coactivateur de récepteurs nucléaires
Wynshaw-Boris et al. Regulation of gene transcription by multiple hormones: organization of regulatory elements

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97532274

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA